Skip to main content

Table 1 Comparison of histopathological and clinical findings between PACM and no PACM groups of the case–control study

From: Clinicopathological characteristics of pancreatic acinar cell metaplasia associated with Helicobacter pylori infection

  PACM group (n = 10) no PACM group (n = 30) P-value*
A2    
Inflammation 2.3 ± 0.46 2.8 ± 0.48 0.003
Activity 1 ± 0.63 1.37 ± 0.71 0.14
Atrophy 1.1 ± 0.7 1.37 ± 0.91 0.48
IM 0.3 ± 0.64 0.77 ± 1.12 0.27
B2    
Inflammation 1.8 ± 0.6 2.6 ± 0.55 0.001
Activity 1 ± 0.89 1.13 ± 0.56 0.39
Atrophy 0.22 ± 0.42 0.5 ± 0.72 0.3
IM 0 ± 0 0.06 ± 0.36 0.56
Endoscopic atrophy 2.2 ± 1.25 3.6 ± 1.58 0.02
Serum gastrin (pg/mL) 145 ± 102.2 202 ± 112.4 0.08
  1. Data are shown as mean scores ± standard error
  2. PACM, pancreatic acinar cell metaplasia; IM, Intestinal metaplasia; USS, updated Sydney System; A2, the greater curvature of the antrum; B2, the greater curvature of the corpus
  3. *P-value were calculated by the Mann–Whitney U-test